About Acclarent
Acclarent is a company based in Irvine (United States) founded in 2004 was acquired by Integra LifeSciences in December 2023.. Acclarent has raised $61 million across 3 funding rounds from investors including Integra LifeSciences, Johnson & Johnson Innovation – JJDC and NEA. The company has 349 employees as of December 31, 2011. Acclarent operates in a competitive market with competitors including Intersect ENT, Tivic Health, Entellus Medical, MyPurMist and Dalent Medical, among others.
- Headquarter Irvine, United States
- Employees 349 as on 31 Dec, 2011
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Acclarent, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$61 M (USD)
in 3 rounds
-
Latest Funding Round
$26 M (USD), Series D
Jan 12, 2009
-
Investors
Integra LifeSciences
& 6 more
-
Employee Count
349
as on Dec 31, 2011
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Acclarent
Acclarent has successfully raised a total of $61M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $26 million completed in January 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $26.0M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2009 | Amount | Series D - Acclarent | Valuation |
investors |
|
| Apr, 2007 | Amount | Series C - Acclarent | Valuation | Meritech | |
| Dec, 2005 | Amount | Series B - Acclarent | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Acclarent
Acclarent has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Integra LifeSciences, Johnson & Johnson Innovation – JJDC and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Investments are made in life sciences firms across all stages.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Acclarent
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Acclarent
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Acclarent Comparisons
Competitors of Acclarent
Acclarent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intersect ENT, Tivic Health, Entellus Medical, MyPurMist and Dalent Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug-releasing implants for sinusitis treatment are developed.
|
|
| domain | founded_year | HQ Location |
Bioelectronic devices for sinusitis pain relief are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive products for chronic sinusitis treatment are developed.
|
|
| domain | founded_year | HQ Location |
Medical humidification devices are developed with patented CFV technology.
|
|
| domain | founded_year | HQ Location |
Balloon-based sinus dilation devices are developed for sinusitis treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Acclarent
Frequently Asked Questions about Acclarent
When was Acclarent founded?
Acclarent was founded in 2004 and raised its 1st funding round 1 year after it was founded.
Where is Acclarent located?
Acclarent is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Who is the current CEO of Acclarent?
Jeff Hopkins is the current CEO of Acclarent.
Is Acclarent a funded company?
Acclarent is a funded company, having raised a total of $61M across 3 funding rounds to date.
How many employees does Acclarent have?
As of Dec 31, 2011, the latest employee count at Acclarent is 349.
What does Acclarent do?
Acclarent was founded in 2004 in Irvine, United States, within the medical device sector. Minimally invasive technologies for ear, nose, and throat procedures are developed by the company, focusing on balloon-based sinuplasty to address rhinosinusitis and persistent Eustachian tube dysfunction. Nasal anatomy is preserved through these tools, which support surgeons in clinical applications across the region.
Who are the top competitors of Acclarent?
Acclarent's top competitors include Tivic Health, Intersect ENT and Entellus Medical.
Who are Acclarent's investors?
Acclarent has 7 investors. Key investors include Integra LifeSciences, Johnson & Johnson Innovation – JJDC, NEA, Delphi Ventures, and Versant Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.